SCHEMBL23925833

SCHEMBL23925833

CC(CNC(=O)O)n1cnc2c(-c3cccnc3)nc(-c3ccc(Cl)cc3)cc2c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 3/20 0.38
PSD A5PKW4 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
ADORA2A P29274 2/20 0.37
ADORA1 P30542 2/20 0.37
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
GAA P10253 1/20 0.36
KDM4E B2RXH2 5/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 3/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23950771 0.93 SCD (0.37) EGLN1PSDPDE4APDE4CPDE4D
SCHEMBL30101944 0.89 HTT (0.36) EGLN1PSDCYP1A2CYP3A4CYP2C9
SCHEMBL23925644 0.89 EGLN1 (0.41) EGLN1ADORA2AADORA1F9DYRK1A
SCHEMBL23390221 0.88 PSD (0.40) EGLN1PSDPDE4APDE4CPDE4D
SCHEMBL30101948 0.88 PSD (0.40) EGLN1PSDPDE4APDE4CPDE4D
SCHEMBL23390225 0.88 PSD (0.40) EGLN1PSDPDE4APDE4CPDE4D
SCHEMBL23950302 0.88 PSD (0.36) PSDPDE4APDE4CPDE4DADORA2A
SCHEMBL23950594 0.87 PSD (0.40) PSDPDE4APDE4CPDE4DADORA2A
SCHEMBL23950299 0.87 PSD (0.37) PSDADORA2AADORA1CYP1A2CYP3A4
SCHEMBL23925514 0.86 USP5 (0.42) PSDPDE4APDE4CPDE4DADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2023-05-11 US disclosed
EP-4136088-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS Dong-A ST Co., Ltd. (KR) 2023-02-22 EP disclosed
WO-2021210970-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS AHR, ARNT, AIPL1 EGLN1 201/4885PSD 3850/4885PDE4A 1967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.